ライブ
Endpoints NewsGoHealth files for bankruptcy, as Medicare Advantage insurers pull backAgilentHow Investors May Respond To Agilent Technologies (A) Expanding AI-Enabled Lab Solutions And Oncology Diagnostics - simplywall.stBioPharma DiveTango data add to growing momentum for pancreatic cancer drugsThermo FisherThermo Fisher Scientific Introduces New Mass Spectrometry Platforms and AI Software - Clinical Lab ProductsBioPharma DiveIncyte to buy blood disorder drug in possibly $2B dealFierceBiotechClinical-stage cancer biotech Treeline sees path to public markets via reverse mergerFierceBiotechADA: Dexcom CGM shows benefit in non-insulin diabetes patientsBioPharma DiveJ&J to acquire Firefly, maker of ‘degrader’ antibody drugs, for up to $1BEndpoints NewsTreeline to go public via reverse merger with Standard BioToolsRoche MediaThis Biotech Stock Is Popping 10% on $2.3 Billion Roche Deal for Blood Cancer Drug - Barron'sBioPharma DiveADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ optionFierceBiotechResmed snaps up Noctrix Health in $340M sleep tech deal
Endpoints News 2025年12月16日

Verge Genomics' ALS drug fails as biotech shifts to partner model

Verge Genomics' ALS drug fails as biotech shifts to partner model

原文
本文は利用できません。元の情報源をご確認ください。